Navigating treatment decisions in NSCLC

Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions need to take into account potential side effects. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA  Pathologist: Prof. Keith Kerr, UK Oncology nurse practitioner: Dr Marianne Davies, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics,  Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/